Setup News Ticker
Searching for 'Stock Group'. (Return)

MarketWatch MarketPulseAug 13, 2020
Novavax's stock surges after supply deal with South Korea's SK Group for COVID-19 vaccine candidate
Shares of Novavax Inc. rallied 2.8% in premarket trading Thursday, after the biotechnology company said it has entered into a development and supply agreement with South Korea-based SK Group subsidiary SK Bioscience for the antigen component of Novavax's COVID-19 vaccine candidate, NVX-CoV2373. The companies have also signed a letter of intent with the Republic of Korea's Ministry of Health and Welfare to make NVX-CoV2373 available in South Korea, as well as for the global market. Under terms of the agreement, SK Bioscience will make the vaccine antigen component during the pandemic period. Phase 1 data of Phase 1/2 clinical trial showed that NVX-CoV2373 was well tolerated and generated a "robust" antibody response. Novavax's stock has more than tripled (up 205.9%) over the past three months through Wednesday, while the iShares Nasdaq Biotechnology ETF has gained 3.3% and the S&P 500 has advanced 19.9%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit for more information on this news.

Yahoo BusinessAug 13, 2020
Gold Advances After Wild Swings as Investors Weigh Next Steps
(Bloomberg) -- Gold headed for back-to-back gains following wild swings as investors weighed the outlook for the metal's record-setting rally, tracking moves in bond yields, a weaker dollar, as well as an uptick in risk appetite.Spot bullion climbed, while futures were little changed. This comes after prices tumbled on Tuesday, then swung in a wide arc on Wednesday, as last-week's rally likely spurred some technical selling and profit-taking. Meanwhile, most Asian stocks advanced Thursday and were on course to erase this year's declines as the global equity rally that's driven shares higher since March continued to strengthen.Gold and silver have resumed their uptrend after the correction and remain among the best performing commodities this year, aided by negative real yields and vast stimulus to combat the fallout from the coronavirus pandemic. Goldman Sachs Group Inc. has described gold as the currency of last resort amid an inflation threat to the dollar, and forecast further gains above $2,000 an ounce."Gold's roller-coaster ride is far from over as bond yields will likely remain volatile for the rest of the summer," said Edward Moya, senior market analyst at Oanda Corp. "The relentless pace higher for gold will moderate but the outlook still warrants a strong stretch of fresh, record highs."Spot gold traded 1% higher at $1,935.45 an ounce at 11:54 a.m. in Singapore. On Tuesday, prices dropped 5.7%, the biggest one-day loss in seven years, following a rally to an all-time high of $2,075.47 last week. Futu
CoronavirusVaccine latest pandemic Trump relief
COVID-19Vaccine cases deaths NBC Coronavirus
Trumpcoronavirus Harris Schools push Will
Stockmarket futures S&P record Tesla
Millionclaims below Jobless coronavirus Weekly
Claimsmillion Jobless below time Weekly
Pandemiccoronavirus Economic Report million During
dealCOVID-19 stock vaccine trade outbreak
StocksBuy making biggest moves record
Businesshelp Hit How pandemic Automation

Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money Real Estate News Analysis Indicators
Enterprise Application News
Forbes Headlines
Forbes Social Media News - China, Economy & Trade - Financial Markets - Hedge Funds - Telecoms - US
Google Business News
Google Market News
HBS Working Knowledge
INSEAD Knowledge
International Tax Review
L.S. Starrett News
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money Updates: News Digest
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2020 CEOExpress Company LLC